Individual differences |
Methods | Statistics | Clinical | Educational | Industrial | Professional items | World psychology |
[[Image:|220px|Benztropine chemical structure]]
| CAS number |
| ATC code |
| PubChem |
| DrugBank |
|Molecular weight||307.429 g/mol|
|Elimination half-life||3-6 hours|
|Routes of administration||oral, IM, IV|
- Drug-induced parkinsonism, akathisia and acute dystonia;
- Parkinson disease; and
- Idiopathic or secondary dystonia.
Benztropine is also sometimes used for the treatment of dystonia, a rare disorder that causes abnormal muscle contraction, resulting in twisting postures of limbs, trunk, or face.
These are principally anticholinergic:
- Dry mouth
- Blurred vision
- Cognitive changes
- Urinary retention
- Psychosis (usually in overdose)
Some studies suggest that use of anticholinergics increases the risk of tardive dyskinesia, a long-term side effect of antipsychotics. Other studies have found no association between anticholinergic exposure and risk of developing tardive dyskinesia.
|This page uses Creative Commons Licensed content from Wikipedia (view authors).|